Insider · CIK 0001828131
Kieran O'Kane
officer
Files at BDSX (BIODESIX INC). First filing Nov 13, 2024, latest Nov 13, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $17k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BDSX: BIODESIX INC
BDSXOct 9, 2026 · close 26.02
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | BIODESIX INC | $191 25 shares | -0% | +71% from low-76% from high | |
| 15Weak | BIODESIX INC | $198 476 shares | -0% | +75% from low-79% from high | |
| 15Weak | BIODESIX INC | $170 477 shares | -0% | +3% from low-80% from high | |
| 20Weak | BIODESIX INC | $16k 17,527 shares | -12% | - | |
| 15Weak | BIODESIX INC | $645 462 shares | -0% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | BDSX BIODESIX INC | MOption exercise Common Stock | +75 | - | - | 7,387 | Nov 13, 2025 |
| Nov 10, 2025 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -25 | $7.62 | $191 | 7,362 | Nov 13, 2025 |
| Nov 10, 2025 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -75 | $0.00 | $0 | 73 | Nov 13, 2025 |
| Aug 12, 2025 | BDSX BIODESIX INC | MOption exercise Common Stock | +1,489 | - | - | 140,541 | Aug 14, 2025 |
| Aug 13, 2025 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -476 | $0.42 | $198 | 140,065 | Aug 14, 2025 |
| Aug 12, 2025 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -1,489 | $0.00 | $0 | 2,979 | Aug 14, 2025 |
| May 9, 2025 | BDSX BIODESIX INC | MOption exercise Common Stock | +1,490 | - | - | 139,529 | May 13, 2025 |
| May 12, 2025 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -239 | $0.36 | $86 | 139,290 | May 13, 2025 |
| May 13, 2025 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -238 | $0.35 | $84 | 139,052 | May 13, 2025 |
| May 9, 2025 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -1,490 | $0.00 | $0 | 4,468 | May 13, 2025 |
| Feb 20, 2025 | BDSX BIODESIX INC | AGrant or award Restricted Stock Unitsderivative | +117,500 | $0.00 | $0 | 117,500 | Feb 26, 2025 |
| Feb 20, 2025 | BDSX BIODESIX INC | AGrant or award Stock Options (Right to buy)derivative | +235,000 | $0.00 | $0 | 235,000 | Feb 26, 2025 |
| Feb 20, 2025 | BDSX BIODESIX INC | AGrant or award Stock Options (Right to buy)derivative | +87,319 | $0.00 | $0 | 87,319 | Feb 26, 2025 |
| Feb 10, 2025 | BDSX BIODESIX INC | MOption exercise Common Stock | +48,118 | - | - | 145,566 | Feb 12, 2025 |
| Feb 11, 2025 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -17,527 | $0.92 | $16k | 128,039 | Feb 12, 2025 |
| Feb 10, 2025 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -1,489 | $0.00 | $0 | 5,958 | Feb 12, 2025 |
| Feb 10, 2025 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -30,534 | $0.00 | $0 | 61,067 | Feb 12, 2025 |
| Feb 10, 2025 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -16,095 | $0.00 | $0 | 48,286 | Feb 12, 2025 |
| Nov 8, 2024 | BDSX BIODESIX INC | MOption exercise Common Stock | +1,490 | - | - | 97,910 | Nov 13, 2024 |
| Nov 11, 2024 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -238 | $1.39 | $331 | 97,672 | Nov 13, 2024 |
| Nov 12, 2024 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -224 | $1.40 | $314 | 97,448 | Nov 13, 2024 |
| Nov 8, 2024 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -1,490 | $0.00 | $0 | 7,447 | Nov 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.